Appeals Court Reinstates In-Person Requirement for Abortion Pills Nationwide

A federal appeals court has temporarily reinstated a rule requiring that abortion pills be obtained in person, impacting access to medication abortion, which has surged since the Supreme Court's decision to overturn Roe v. Wade. The ruling from the 5th US Circuit Court of Appeals is seen as a significant win for anti-abortion advocates, as medication abortions now represent about two-thirds of all abortions in the U.S. This decision stems from a lawsuit by Louisiana against the FDA, claiming that remote access to abortion pills undermines state laws prohibiting the procedure. Critics argue this ruling could severely restrict access to safe abortion methods, particularly for vulnerable populations. The case highlights ongoing legal battles over abortion access in the U.S.

Key Details: • The ruling affects the nationwide availability of mifepristone, a key abortion drug. • Abortion pills will now require in-person consultations, reversing recent telehealth provisions. • Louisiana's lawsuit against the FDA claims remote access violates state laws. • The decision may disproportionately impact women in rural areas and those facing domestic violence.